ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,383,529, issued on Aug. 12, was assigned to Piramal Enterprises Ltd. (Mumbai, India).
"Pharmaceutical combination for the treatment of cancer" was invented by Owe Orwar (Hovas, Sweden), Sreesha Srinivasa (Bangalore, India) and Prabha Mishra (Thane, India).
According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention relates to a pharmaceutical combination comprising a CDK inhibitor and at least one antioxidant enzyme inhibitor for use in the treatment of cancer. The present invention also relates to a method for the treatment of cancer comprising administering to a subject in need thereof, a therapeutically effective amount of a CDK inhibitor and ...